Structure and dynamics of the chromatin remodeler ALC1 bound to a PARylated nucleosome
- PMID: 34486521
- PMCID: PMC8463071
- DOI: 10.7554/eLife.71420
Structure and dynamics of the chromatin remodeler ALC1 bound to a PARylated nucleosome
Abstract
The chromatin remodeler ALC1 is recruited to and activated by DNA damage-induced poly(ADP-ribose) (PAR) chains deposited by PARP1/PARP2/HPF1 upon detection of DNA lesions. ALC1 has emerged as a candidate drug target for cancer therapy as its loss confers synthetic lethality in homologous recombination-deficient cells. However, structure-based drug design and molecular analysis of ALC1 have been hindered by the requirement for PARylation and the highly heterogeneous nature of this post-translational modification. Here, we reconstituted an ALC1 and PARylated nucleosome complex modified in vitro using PARP2 and HPF1. This complex was amenable to cryo-EM structure determination without cross-linking, which enabled visualization of several intermediate states of ALC1 from the recognition of the PARylated nucleosome to the tight binding and activation of the remodeler. Functional biochemical assays with PARylated nucleosomes highlight the importance of nucleosomal epitopes for productive remodeling and suggest that ALC1 preferentially slides nucleosomes away from DNA breaks.
Keywords: ALC1/CHD1L; PARP1; chromatin; chromosomes; gene expression; human; molecular biophysics; nucleosome; poly(ADP-ribose)ylation; remodeling; structural biology.
© 2021, Bacic et al.
Conflict of interest statement
LB, GG, AS, LL, KB, DD, MH, GH none, SB is co-founder and VP Science Strategy at Artios Pharma Ltd, SD Reviewing editor, eLife
Figures
Similar articles
-
Activation of the SNF2 family ATPase ALC1 by poly(ADP-ribose) in a stable ALC1·PARP1·nucleosome intermediate.J Biol Chem. 2012 Dec 21;287(52):43527-32. doi: 10.1074/jbc.M112.401141. Epub 2012 Nov 6. J Biol Chem. 2012. PMID: 23132853 Free PMC article.
-
Asymmetric nucleosome PARylation at DNA breaks mediates directional nucleosome sliding by ALC1.Nat Commun. 2024 Feb 2;15(1):1000. doi: 10.1038/s41467-024-45237-8. Nat Commun. 2024. PMID: 38307862 Free PMC article.
-
Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1.Mol Cell. 2017 Dec 7;68(5):847-859.e7. doi: 10.1016/j.molcel.2017.10.017. Mol Cell. 2017. PMID: 29220652 Free PMC article.
-
PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling.Int J Mol Sci. 2021 May 12;22(10):5112. doi: 10.3390/ijms22105112. Int J Mol Sci. 2021. PMID: 34066057 Free PMC article. Review.
-
Mechanistic insight into the role of Poly(ADP-ribosyl)ation in DNA topology modulation and response to DNA damage.Mutagenesis. 2020 Feb 13;35(1):107-118. doi: 10.1093/mutage/gez045. Mutagenesis. 2020. PMID: 31782485 Review.
Cited by
-
The expanding universe of PARP1-mediated molecular and therapeutic mechanisms.Mol Cell. 2022 Jun 16;82(12):2315-2334. doi: 10.1016/j.molcel.2022.02.021. Epub 2022 Mar 9. Mol Cell. 2022. PMID: 35271815 Free PMC article. Review.
-
High-throughput screening assay for PARP-HPF1 interaction inhibitors to affect DNA damage repair.Sci Rep. 2024 Feb 16;14(1):3875. doi: 10.1038/s41598-024-54123-8. Sci Rep. 2024. PMID: 38365924 Free PMC article.
-
CHD1L Regulates Cell Survival in Breast Cancer and Its Inhibition by OTI-611 Impedes the DNA Damage Response and Induces PARthanatos.Int J Mol Sci. 2024 Aug 6;25(16):8590. doi: 10.3390/ijms25168590. Int J Mol Sci. 2024. PMID: 39201277 Free PMC article.
-
ADP-ribosylation from molecular mechanisms to therapeutic implications.Cell. 2023 Oct 12;186(21):4475-4495. doi: 10.1016/j.cell.2023.08.030. Cell. 2023. PMID: 37832523 Free PMC article. Review.
-
Functionalized graphene-oxide grids enable high-resolution cryo-EM structures of the SNF2h-nucleosome complex without crosslinking.Nat Commun. 2024 Mar 12;15(1):2225. doi: 10.1038/s41467-024-46178-y. Nat Commun. 2024. PMID: 38472177 Free PMC article.
References
-
- Abbott JM, Zhou Q, Esquer H, Pike L, Broneske TP, Rinaldetti S, Abraham AD, Ramirez DA, Lunghofer PJ, Pitts TM, Regan DP, Tan AC, Gustafson DL, Messersmith WA, LaBarbera DV. First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer. Molecular Cancer Therapeutics. 2020;19:1598–1612. doi: 10.1158/1535-7163.MCT-20-0106. - DOI - PMC - PubMed
-
- Ahel D, Horejsí Z, Wiechens N, Polo SE, Garcia-Wilson E, Ahel I, Flynn H, Skehel M, West SC, Jackson SP, Owen-Hughes T, Boulton SJ. Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1. Science. 2009;325:1240–1243. doi: 10.1126/science.1177321. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous
